Key Takeaways
- Shares of IBM fell more than 4% in Thursday’s premarket session following Accenture’s reduced fiscal 2026 revenue forecast
- Accenture revised its full-year revenue projection to $71.76B–$72.46B, trimming the prior high-end target of $73.16B
- Despite Accenture’s Q3 earnings per share of $3.80 surpassing expectations, quarterly sales of $18.7B fell short of the $18.745B target
- According to GF Value metrics, IBM trades approximately 9.9% above fair value at $262.35, earning a GF Score of 78/100
- IBM’s second-quarter financial results are scheduled for July 22, with Wall Street projecting EPS of $3.00 and sales of $17.85B
Shares of International Business Machines took a significant hit Thursday morning following Accenture’s decision to lower the upper bound of its fiscal 2026 revenue projection, creating a ripple effect throughout the IT services industry.
International Business Machines Corporation, IBM
In premarket activity, IBM was changing hands at $251.01, representing a 4.32% decline. The stock had previously closed at $262.35 on June 17, marking a 3.1% drop from the session before.
The decline wasn’t the result of any IBM-specific news. Instead, market participants reacted to Accenture’s revised financial outlook.
Accenture adjusted its annual revenue projection to a tighter band of $71.763 billion to $72.460 billion. This represents a reduction from the previously stated top end of $73.157 billion. The Street had been anticipating $74.006 billion for the full fiscal year.
This type of guidance adjustment typically creates spillover effects across comparable companies in the sector — and IBM was no exception.
From an earnings perspective, Accenture delivered upside on profitability. Third-quarter diluted earnings per share reached $3.80, exceeding the $3.69 projection. However, quarterly sales of $18.700 billion came up short of the $18.745 billion estimate, and the revised outlook weighed on sentiment.
Accenture’s CEO Julie Sweet highlighted robust artificial intelligence demand, citing 104 client contracts worth $100 million or more year-to-date through the quarter, representing a 13% increase. The firm also revealed plans to take a controlling interest in Dragos while acquiring runZero and NetRise in full, focusing on the operational technology cybersecurity space.
IBM’s Second-Quarter Results Due July 22
IBM’s quarterly financial disclosure is set for July 22. The consensus among analysts calls for earnings per share of $3.00 alongside revenue of $17.85 billion for the second quarter.
During the first quarter, IBM delivered earnings per share of $1.91, topping the $1.81 forecast. Sales reached $15.92 billion, exceeding the $15.66 billion expectation. This extended the company’s earnings beat streak to eight straight quarters — a pattern investors will monitor closely when the next report arrives.
Assessing IBM’s Current Valuation
Based on GuruFocus analysis, IBM’s GF Value stands at $238.63, indicating the stock was trading at approximately a 9.9% premium relative to this fair value benchmark at $262.35.
IBM’s trailing price-to-earnings ratio of 23.2x registers modestly below its five-year median of 24.4x. The forward-looking P/E ratio stands at 21.1x.
The company’s GF Score of 78/100 suggests above-average positioning compared to industry counterparts, with profitability representing the most robust metric at 8/10. Financial strength registers at 5/10, while momentum scores 4/10 — the latter aligning with Thursday’s negative price action.
A notable observation: insider buying or selling activity has been absent over the trailing three-month period.
IBM’s 52-week trading range extends from $212.34 to $332.46, positioning Thursday’s premarket level of $251.01 in the lower portion of that spectrum.
The upcoming focal point for IBM investors remains the July 22 earnings announcement.





